HIV, including sudden cardiac death, pulmonary hypertension (PH), and heart failure (7) (8) (9) (10) (11) . In this issue of JACC: Heart Failure, Secemsky et al. (12) further contribute to our understanding of the broad spectrum of HIV-related CVD by showing that HIVinfected patients have significantly higher rates of diastolic dysfunction and PH. The authors also show for the first time a strong association between the cardiac biomarkers ST2 and growth differentiation factor (GDF)-15 and cardiac dysfunction and mortality in an HIV-infected cohort.
The higher rates of diastolic dysfunction in this relatively young group of HIV-infected patients may be due to a number of factors, including an increased rate of underlying occult coronary artery disease and possibly higher rates of cardiac fibrosis (12) .
Recent imaging studies have reported a high prevalence of myocardial fibrosis in asymptomatic HIVinfected patients (13) . Cardiac fibrosis may also be increased in HIV-infected patients due to heightened inflammation, accelerated aging, and intensified oxidative stress from antiretroviral therapy (14) (15) (16) . The strong association between higher levels of ST2 and diastolic dysfunction in this study also suggests the possibility of increased cardiac fibrosis, as ST2 is a mediator of this pathological process (17) . In addition, the study findings high- Institute. Dr. Shah has reported that she has no relationships relevant to the contents of this paper to disclose. The most novel finding from this study (12) but also in all patients with CVD.
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